Adcetris is a prescription medication used to treat:
- Hodgkin’s lymphoma
- systemic anaplastic large cell lymphoma (sALCL; a type of non-Hodgkin lymphoma)
This medication is used after other treatments have been unsuccessful.
Adcetris may be prescribed for other uses. Ask your doctor or pharmacist for more information.
Common side effects include:
- tiredness
- nausea
- diarrhea
- low white blood cell counts
- anemia
- tingling sensation
This is not a complete list of Adcetris side effects. Ask your doctor or pharmacist for more information.
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Adcetris (generic: brentuximab vedotin) is a prescription medication used to treat Hodgkin’s lymphoma and systemic anaplastic large cell lymphoma (sALCL; a type of non-Hodgkin lymphoma) when other treatments have not been successful. This medication belongs to a group of drugs called antibody-drug conjugates. It attaches to and enters cancer cells and kills them.
Adcetris comes in an injectable form to be given directly into a vein and infused over 30 minutes by a healthcare provider. It is usually injected once every 3 weeks.
Common side effects include tiredness, nausea, and diarrhea.
WARNING: PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY (PML)
JC virus infection resulting in PML and death can occur in patients receiving Adcetris.